Analyze Diet
Veterinary immunology and immunopathology1989; 23(1-2); 41-49; doi: 10.1016/0165-2427(89)90108-6

Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.

Abstract: Antibody responses in horses with equine infectious anemia virus (EIAV) were examined to determine their cross-neutralizing capacity. Antibodies induced by infection with any of six biologically cloned variants of EIAV cross-neutralized multiple variants from the group. Anti-EIAV antibody was found in both the IgG and IgG(T) subclasses in plasmas with virus-neutralizing activity and the majority of antiviral antibody was of the IgG(T) subclass. Depletion of IgG(T) did not increase the neutralization indexes of either neutralizing or non-neutralizing plasma samples.
Publication Date: 1989-11-30 PubMed ID: 2559537DOI: 10.1016/0165-2427(89)90108-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the response of antibodies in horses infected with the equine infectious anemia virus (EIAV), particularly their capability to neutralize multiple variants of the virus. Study findings reveal that antibodies triggered by any of six biologically cloned variants of EIAV can cross-neutralize multiple variants. Moreover, Anti-EIAV antibody was detected in both IgG and IgG(T) subclasses, with the majority being of the IgG(T) type.

Examining Antibody Responses

  • The researchers investigated the antibody responses in horses with the equine infectious anemia virus (EIAV). The focus of the study was to determine the ability of these antibodies to cross-neutralize.
  • The EIAV infection in horses was induced by any of the six biologically cloned variants of the EIAV. Previous research has shown that adopting this cloning method helps researchers better understand the behavior of the virus.
  • This investigation revealed that the antibodies can cross-neutralize several virus variants. Cross-neutralization refers to the capability of an antibody to neutralize different types or strains of a virus. This particular capability is crucial in addressing outbreaks of new strains, as it could potentially simplify and expedite the development of vaccines.

Antibody Subclasses in Horses Infected with EIAV

  • Antibodies found in horses with EIAV were present in two subclasses: the IgG and IgG(T) subclasses.
  • These subclasses were found in the plasma, the liquid part of the blood where antibodies are usually found, along with other components.
  • The most abundant type of antiviral antibody detected was the IgG(T) subclass. This particular subclass of antibodies, typically made in response to virus infections.
  • The researchers also examined the effect of depleting the IgG(T) subclass on the neutralization indexes. The neutralization index is a measure of the amount of virus that can be neutralized by a certain volume of plasma. Interestingly, the depletion of IgG(T) did not increase these indexes, regardless of whether the plasma sample was neutralizing or non-neutralizing.

Cite This Article

APA
O'Rourke KI, Perryman LE, McGuire TC. (1989). Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet Immunol Immunopathol, 23(1-2), 41-49. https://doi.org/10.1016/0165-2427(89)90108-6

Publication

ISSN: 0165-2427
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 23
Issue: 1-2
Pages: 41-49

Researcher Affiliations

O'Rourke, K I
  • Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164.
Perryman, L E
    McGuire, T C

      MeSH Terms

      • Animals
      • Antibodies, Viral / biosynthesis
      • Antibodies, Viral / classification
      • Antibodies, Viral / immunology
      • Cross Reactions
      • Equine Infectious Anemia / immunology
      • Horses
      • Immunoglobulin G / biosynthesis
      • Immunoglobulin G / immunology
      • Infectious Anemia Virus, Equine / immunology
      • Neutralization Tests

      Grant Funding

      • AI24166 / NIAID NIH HHS
      • AI24291 / NIAID NIH HHS

      Citations

      This article has been cited 10 times.
      1. Taylor SD, Leib SR, Wu W, Nelson R, Carpenter S, Mealey RH. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.. J Virol 2011 Jul;85(13):6814-8.
        doi: 10.1128/JVI.00077-11pubmed: 21543497google scholar: lookup
      2. Cappelli K, Capomaccio S, Cook FR, Felicetti M, Marenzoni ML, Coppola G, Verini-Supplizi A, Coletti M, Passamonti F. Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.. J Clin Microbiol 2011 Jan;49(1):27-33.
        doi: 10.1128/JCM.01311-10pubmed: 21084503google scholar: lookup
      3. Taylor SD, Leib SR, Carpenter S, Mealey RH. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.. J Virol 2010 Jul;84(13):6536-48.
        doi: 10.1128/JVI.00218-10pubmed: 20392850google scholar: lookup
      4. Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.. Vet Immunol Immunopathol 2008 Jan 15;121(1-2):8-22.
        doi: 10.1016/j.vetimm.2007.07.011pubmed: 17727961google scholar: lookup
      5. Mealey RH, Sharif A, Ellis SA, Littke MH, Leib SR, McGuire TC. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.. Virology 2005 Aug 15;339(1):110-26.
        doi: 10.1016/j.virol.2005.05.025pubmed: 15979679google scholar: lookup
      6. Maury W, Thompson RJ, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.. J Virol 2005 May;79(9):5653-64.
      7. Mealey RH, Leib SR, Pownder SL, McGuire TC. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.. J Virol 2004 Sep;78(17):9295-305.
      8. Hammond SA, Li F, McKeon BM Sr, Cook SJ, Issel CJ, Montelaro RC. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.. J Virol 2000 Jul;74(13):5968-81.
      9. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus.. Virus Res 1994 May;32(2):111-38.
        doi: 10.1016/0168-1702(94)90038-8pubmed: 8067050google scholar: lookup
      10. Perryman LE, O'Rourke KI, Mason PH, McGuire TC. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.. Immunology 1990 Dec;71(4):592-4.
        pubmed: 1703988